CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Erchonia GVLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04895618
NCT04895618N/ACompleted
CompareCT.gov

An Evaluation of the Effect of the Erchonia® GVL Green and Violet Laser on Neck and Shoulder Pain

Erchonia Corporation·interventional·Posted May 20, 2021·Updated Aug 21, 2023

In Brief

A clinical study evaluating Erchonia GVL for Musculoskeletal Pain. Completed, enrolled 43 participants across 3 sites.

Detailed Summary

This study is to see if applying green and violet low level laser light to the neck and shoulders can help to reduce pain in the neck and shoulders.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMusculoskeletal Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 20, 2021
Enrollment StartNov 11, 2020
Primary CompletionMay 18, 2022
Study CompletionMay 20, 2022
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.1 years ago

Interventions

Erchonia GVLdevice

Single treatment with the Erchonia GVL to the neck and shoulders. The treatment applies 520 nanometers (nm) green diode light and 405 nm violet diode light simultaneously.